https://www.fool.com/personal-finance/2006/10/31/invest-like-the-mummy.aspx
https://www.fool.com/investing/general/2007/03/30/another-genetic-sequencer-gobbled-up.aspx
https://www.fool.com/investing/dividends-income/2006/11/30/dueling-fools-dividends.aspx
https://www.fool.com/investing/high-growth/2006/10/30/sigmaaldrich-ekes-out-organic-growth.aspx
https://www.fool.com/investing/high-growth/2006/08/15/sirna-battles-genes-gone-bad.aspx
https://www.fool.com/investing/general/2010/10/25/the-state-of-oncology-and-the-future-for-biotech-i.aspx
https://www.fool.com/investing/general/2007/01/30/molecular-devices-acquired.aspx
https://www.fool.com/investing/high-growth/2007/02/12/affymetrix-expressing-profits.aspx
https://www.fool.com/investing/general/2007/03/28/shine-a-little-light-on-me.aspx
https://www.fool.com/investing/high-growth/2006/09/28/a-second-selloff-at-molecular-devices.aspx
https://www.fool.com/investing/high-growth/2006/11/06/validation-for-a-biotechnology-firm.aspx
https://www.fool.com/investing/high-growth/2010/10/27/companion-diagnostics-in-cancer-drug-development.aspx
https://www.fool.com/investing/high-growth/2006/09/27/qiagen-biotech-support.aspx
https://www.fool.com/investing/mutual-funds/2006/11/17/not-your-fathers-index-funds.aspx
https://www.fool.com/investing/dividends-income/2006/10/05/rnai-nobel-prizewinning-biotechnology.aspx
https://www.fool.com/investing/high-growth/2006/09/26/biotechs-distant-star.aspx
https://www.fool.com/investing/dividends-income/2006/08/25/adams-coughs-up-some-profits.aspx
https://www.fool.com/investing/high-growth/2006/09/08/gentas-down-but-is-it-out.aspx
https://www.fool.com/investing/high-growth/2007/01/23/winwin-for-abbott-and-ge.aspx
https://www.fool.com/investing/dividends-income/2006/08/30/foolish-book-review-quotthe-future-for-investorsqu.aspx
https://www.fool.com/investing/general/2010/10/26/the-changing-landscape-of-pharmaceutical-informati.aspx
https://www.fool.com/investing/high-growth/2007/01/04/picks-and-shovels-of-biotechnology.aspx
https://www.fool.com/investing/value/2006/11/30/dueling-fools-dividends-rebuttal.aspx
https://www.fool.com/investing/high-growth/2007/03/27/beckman-coulter-gets-diagnostic.aspx
https://www.fool.com/investing/small-cap/2006/10/31/invest-like-dr-jekyll.aspx
https://www.fool.com/investing/general/2010/10/26/where-we-are-in-the-war-on-cancer.aspx
https://www.fool.com/investing/dividends-income/2007/01/19/the-best-drug-stock-for-2007-glaxosmithkline.aspx
https://www.fool.com/investing/general/2010/10/25/the-war-on-cancer-a-long-and-ongoing-struggle.aspx
https://www.fool.com/investing/high-growth/2007/01/25/varian-beams-in-results.aspx
